N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester
|
|
|
- CAS-Nr.
- 137863-20-8
- Englisch Name:
- N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester
- Synonyma:
- Valsartan Related CoMpound C;Valsartan Impurity C;CGP 49841;Valsartan-1;-3-methylbutanoate;Valsartan USP RC C;Valsartan Impurity B;Valsartan Benzyl Ester;Valsartan impurities27;Valsartan EP Impurity B
- CBNumber:
- CB02474429
- Summenformel:
- C31H35N5O3
- Molgewicht:
- 525.64
- MOL-Datei:
- 137863-20-8.mol
|
N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester Eigenschaften
- Schmelzpunkt:
- >71°C (dec.)
- Siedepunkt:
- 720.1±70.0 °C(Predicted)
- Dichte
- 1.180±0.06 g/cm3(Predicted)
- Dampfdruck
- 0-0Pa at 20-25℃
- storage temp.
- Sealed in dry,Room Temperature
- L?slichkeit
- Chloroform (Slightly), Methanol (Slightly)
- pka
- 4.15±0.10(Predicted)
- Farbe
- White to Off-White
- LogP
- 2.43 at 25℃ and pH7.35
- Oberfl?chenspannung
- 59.6-68.1mN/m at 10-100mg/L and 20℃
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Kennzeichnung gef?hrlicher |
Xn |
|
|
| R-S?tze: |
22 |
|
|
| HS Code |
2933997500 |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
| Sicherheit |
| P264 |
Nach Gebrauch gründlich waschen. |
| P264 |
Nach Gebrauch gründlich waschen. |
| P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
| P301+P312 |
BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen. |
| P330 |
Mund ausspülen. |
| P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden
N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 119)Lieferanten
137863-20-8()Verwandte Suche:
- (S)-benzyl2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- Valsartan Benzyl Ester
- L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]- 4-yl]methyl]-, phenylmethyl ester
- (S)-N-Valeryl-N-([2'-(1-H-tetrazole-5-yl)biphenyl-4-yl]-Methyl)valine benzyl ester
- N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester
- (S)-N-Valeryl-N-([2'-(1H-tetrazole-5-yl)biphen-4-yl]methyl)valine benzyl ester
- Valsartan Related Compound C (10 mg) ((S)-N-Valeryl-N-([2'-(1-H-tetrazole-5-yl)biphenyl-4-yl]-methyl)valine benzyl ester)
- Valsartan Benzyl Ester： (S)-N-Valeryl-N-([2'-(1-H-tetrazole)-5-yl)-biphenyl-4-yl]-Methyl)-valine benzyl ester
- Valsartan USP Related CoMpound C
- (S)-Benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoat
- CGP 49841
- N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine phenylmethyl ester
- Benzyl N-Pentanoyl-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-D-valine
- Valsartan Related Compound C (10 mg) (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester)
- Valsartan EP Impurity B
- (S)-benzyl 2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoate
- -3-methylbutanoate
- -Benzyl 2-(N-((2'-(1H-tetrazol-5-yl)
- (S)-Benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutan
- benzyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-
biphenyl]-4-yl)methyl)-N-pentanoyl-
L-valinate
- Valsartan USP RC C
- Valsartan Impurity B
- BenzylN-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate
- (S)-N-(1-benzyloxycarbonyl-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
- Valsartan Impurity 2（Valsartan Related Compound C）
- Valsartan-1
- Valsartan impurity 1/Valsartan EP Impurity B/(S)-Benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- (S)-benzyl 2-(N-((2'-(1H-tetrazol-5-yl)
- Valsartan EP Impurity B (Valsartan USP Related Compound C)
- Valsartan Impurity 2（Valsartan USP RC C）
- Valsartan EP Impurity B/ Valsartan Related Compound C (Valsartan Benzyl Ester)
- Valsartan impurities27
- Valsartan Related Compound C (J0M318)
- Valsartan EP Impurity BQ: What is
Valsartan EP Impurity B Q: What is the CAS Number of
Valsartan EP Impurity B Q: What is the storage condition of
Valsartan EP Impurity B Q: What are the applications of
Valsartan EP Impurity B
- Valsartan Related Compound C (N-valeryl-N-{[2''-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine be (1708795)
- Valsartan Related CoMpound C
- Valsartan Impurity C
- L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl ester (9CI)
- Benzyl 2(S)-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester
- L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl ester (9CI)
- (S)-Benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- 137863-20-8
- C31H35N5O3
- Amino Acids & Derivatives
- Aromatics
- Heterocycles
- Intermediates & Fine Chemicals
- Pharmaceuticals
